Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl 4 -Induced Cirrhotic Rats.
Autor: | Xu H; Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, 208 Huancheng Dong Road, Hangzhou, 310003, China., Xiong J; Department of Geriatrics, Hangzhou Red Cross Hospital, Hangzhou, China., Xu J; Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, 208 Huancheng Dong Road, Hangzhou, 310003, China., Li S; Key Laboratory of Marine Bioresources and Ecology, College of Life Science, Shenzhen University, Shenzhen, China., Zhou Y; Liver Cirrhosis Section, Department of Hepatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Institute of Liver Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Chen D; Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, 208 Huancheng Dong Road, Hangzhou, 310003, China., Cai X; Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou, China., Ping J; Liver Cirrhosis Section, Department of Hepatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Institute of Liver Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Deng M; Department of Emergency, Hangzhou Red Cross Hospital, 208 Huancheng Dong Road, Hangzhou, 310003, China. dengmindoctor@aliyun.com., Chen J; Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, 208 Huancheng Dong Road, Hangzhou, 310003, China. chenjy@medmail.com.cn. |
---|---|
Jazyk: | angličtina |
Zdroj: | Digestive diseases and sciences [Dig Dis Sci] 2017 Oct; Vol. 62 (10), pp. 2801-2811. Date of Electronic Publication: 2017 Aug 16. |
DOI: | 10.1007/s10620-017-4704-x |
Abstrakt: | Background: Impaired intestinal motility may lead to the disruption of gut microbiota equilibrium, which in turn facilitates bacterial translocation (BT) and endotoxemia in cirrhosis. We evaluated the influence of mosapride, a prokinetic agent, on BT and DNA fingerprints of gut microbiota in cirrhotic rats. Methods: A rat model of cirrhosis was set up via subcutaneous injection of carbon tetrachloride (CCl Results: Mosapride treatment to cirrhotic rats significantly reduced the plasma endotoxin level and incidence of BT, accompanied by increased ITR. Cirrhotic rats (including those treated with mosapride) suffered from BT exhibited significantly lower ITR than those who are free of BT. Pearson coefficient indicated a significant and negative correlation between the plasma endotoxin level and ITR. The genomic fingerprints of intestinal microbiota from the three groups fell into three distinctive clusters. In the mosapride-treated group, Shannon's index was remarkably increased compared to the model group. Significantly positive correlation was detected between Shannon's index and ITR. Mosapride did not improve hepatic and intestinal damages and ileal expressions of occludin and ZO-1. Conclusions: Mosapride significantly increases intestinal motility in cirrhotic rats, thus to recover the disordered intestinal microbiota, finally resulting in decreased plasma endotoxin and BT. |
Databáze: | MEDLINE |
Externí odkaz: |